A Placebo-Controlled Study Using VP-102 in the Treatment of External Genital Warts
Study sponsor: Verrica Pharmaceuticals Inc. · VRCA
Primary completion is the date data collection ends for the main study measures, not when results are published.
Primary completion2020-05-21Actual
Enrollment · participants105Actual
Source updated2024-11-27Last update listed in the registry record
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.